Navigation Links
New Treatment For Patients With Paralysis

Investigators designed a combination therapy and tested it on rats with spinal cord contusions -- the most common cause of paralysis in humans.// The combination therapy consisted of transplanted Schwann cells, which is a type of cell that insulates nerve cells, a cell messenger molecule called cyclic AMP, and the antidepressant Rolipram.

Following a spinal cord injury, the body typically does not provide a proper environment for nerve regeneration. However, with the new combination, nerve cells actually reconnected, so healing of the damaged nerve fibers was possible.

For the study researchers injected rats with Rolipram prior to transplanting Schwann cells to preserve cyclic AMP. Cyclic AMP helps enable the growth of nerve fibers that send signals up and down the spinal cord and central nervous system. The rats also received injections of cyclic AMP to promote the growth of nerve fibers past the injury site and into the spinal cord.

Specialists say this research will open up new possibilities for treating patients with spinal cord injuries and they say that more studies are needed to confirm their findings before the treatment is tested in humans.
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:7/8/2008)...Executive Officer of PADRES Contra El Cancer (PADR...tional Spokesperson Fernando Del Rin... July 8 /PRNewswire/ -- In response to media repor...,s cancer diagnosis was,fabricated in order to dra...rboa, M.A., found it imperative to issue the follo...
(Date:7/8/2008)... SKINTASTIC™ is pleased to announce th... latest injectable collagen filler in the Skintast...ents. EVOLENCE® utilizes highly-purified porci...l grafting substance due to its nearly identical s... N. Dallas/Plano, TX (PRWEB) July 8, 2008 - ...
(Date:7/8/2008)...atient Concerns about Delays in Oxygen Orders, Lac.../PRNewswire-USNewswire/ -- The new Medicare,compet...t has created,concern and chaos for beneficiaries,...e medical equipment providers across the country s...n July 1., The bidding program has triggered wide...
(Date:7/8/2008)...y Validates Use of Pharos Innovation,s Proprietary... Healthcare Utilization and ...Newswire/ -- Pharos Innovations, a pioneer,in assi...and financial,performance improvement through a de...day the results from the Iowa Medicaid Congestive ...
Breaking Medicine News(10 mins):Health News:Rumors Dispelled Over Univision Talent Fernando Del Rincon's Cancer Diagnosis Being Fabricated 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 2Health News:Move Over, Popular Beauty Fillers--Here Comes Evolence 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...ed by determining the levels of two proteins in th...mportant role in determining the risk of dementia ... Increased levels of one amyloid protein and decre...associated with a 10-fold increased dementia risk....
...help Alzheimer's patients interact and communicate...rs at Newcastle General Hospital studied the benef...h a teddy bear from her son, reported the online e...ound that Alzheimer's disease patients can lose th...
... something new about exotic particles called solit...litons can carry an electrical charge when traveli... now suggests that solitons have intricate interna...use this information to put the particles to work ...
...e eye because of a city hospital's inability to ac...e black-outs in the middle of a cataract surgery w...onsumer court here//. "It had taken about 15-20 mi... the restoration of power supply, which clearly re...
Other Medicine News:Health News:Solitons Could Power Molecular Electronics, Artificial Muscles 2Health News:Solitons Could Power Molecular Electronics, Artificial Muscles 3
(Date:7/7/2008)...Suggests Kiwifruit is Top Performer in the Body, ... created equal when,it comes to their antioxidant ... in bioavailability compared to other antioxidant-...udy published in the Journal of the,American Colle...nd phytochemicals called flavonoids that,may have ...
(Date:7/3/2008)...July 3 /- Medivation, Inc.,... a teleconference at 5:00,p.m. EDT on Monday, July...d, double-blind, placebo-controlled Phase 2 clinic... Teleconference/Webcast Details, To participate i...stern,time by telephone, please dial 877-419-6590 ...
(Date:7/3/2008)...gland and CAMBRIDGE Massachusetts, July 3,/PRNewsw... of biotechnology company, Jerini AG for an equit...ry angioedema (HAE) product, FIRAZYR(R), to its H... peak annual global sales expected to be around $3...he competitive environment, - Expected to be accr...
(Date:7/1/2008)...Continuing Education Newsletter Series for Healthc...ORHEES, N.J., July 1 /- Clostridium d...at causes disease with a wide spectrum of,severity...olitis and death.,Recurrent CDI can occur in up to...I.(1) These patients are at increased risk of addi...
Breaking Medicine Technology:Kiwifruit: Antioxidant Power in Quantity and Quality 2Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2Brain region that can be stimulated to reduce the cognitive deficits of sleep deprivation identified 10780 1Brain region that can be stimulated to reduce the cognitive deficits of sleep deprivation identified 10780 2Brain region that can be stimulated to reduce the cognitive deficits of sleep deprivation identified 10780 3Trainor Lab characterizes gene essential for prenatal development of nervous system 2098 1Trainor Lab characterizes gene essential for prenatal development of nervous system 2098 2MDS Inc Files Restated 2007 Quarterly Reports Under US GAAP 10779 1New Study Finds Frequent Hand Washing Puts Health Care Workers at Increased Risk for Irritant Contact Dermatitis 10777 1New Study Finds Frequent Hand Washing Puts Health Care Workers at Increased Risk for Irritant Contact Dermatitis 10777 2New Study Finds Frequent Hand Washing Puts Health Care Workers at Increased Risk for Irritant Contact Dermatitis 10777 3New Study Finds Frequent Hand Washing Puts Health Care Workers at Increased Risk for Irritant Contact Dermatitis 10777 4
...sented at Annual Meeting of the American Society o... 4, 2007 -- SciClone Pharmaceuticals,Inc. (Nasdaq...iClone,s lead product candidate thymalfasin (ZADAX...oint in a phase 2 clinical trial,treating patients...ost advanced form of skin cancer. Results showed t...
...--(BUSINESS WIRE)--Jun 4, 2007 - Imprime PGG(TM), ...ances the innate,immune system response, increases...kill cancer cells, according to new preclinical,re...ciety of,Clinical Oncology Annual Meeting in Chica...rsity of,Louisville, Kentucky, studied the synergi...
Other Medicine Technology:Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer,Study 2
...provides all equipment, supplies, and all patient ...okup for setting the patient up in your office (an... professional component, for interpreting the repo...rvice provider to offer full access to your report...
...x, a leading provider of Telemedicine monitoring a...ng service commitment to patients and prescribing ...nstelephonic testing devices that provide enhanced...standard telephone lines. TransMedEx's product lin...
...rdiac Services is a leading provider of telemedici...ned with state-of-the-art technology deliver accur... supports healthcare professionals and clients in ...elecommunications and ECG technology to gather pat...
... has developed a new, integrated technology and se... allows heartbeat-by-heartbeat, ECG monitoring, an...r service is initially focused on helping physicia...me is of the essence in diagnosing and treating ar...
Medicine Products: